INSIDER
Conagra Brands recalls some Birds Eye Broccoli Tots over reports of small rocks, metal fragments in product
Read full article: Conagra Brands recalls some Birds Eye Broccoli Tots over reports of small rocks, metal fragments in productConagra Brands, Inc. has issued a voluntary recall of some of its Birds Eye Broccoli Tots after some consumers reported finding small rocks and metal fragments in the product.
FDA advisory committee votes to approve Johnson & Johnson vaccine booster shots
Read full article: FDA advisory committee votes to approve Johnson & Johnson vaccine booster shotsThe outside panel of experts voted unanimously in favor of offering booster doses of the Johnson & Johnson vaccine at least two months after the first dose.
FDA advisory committee votes to approve Moderna vaccine booster shots for vulnerable groups
Read full article: FDA advisory committee votes to approve Moderna vaccine booster shots for vulnerable groupsThe outside panel of experts voted unanimously in favor of offering Moderna boosters to specific groups of people, at least six months after their second dose.
FDA advisory panel to meet on Moderna, Johnson & Johnson COVID vaccine booster shots
Read full article: FDA advisory panel to meet on Moderna, Johnson & Johnson COVID vaccine booster shotsThe Food and Drug Administrationโs vaccine advisory panel is set to meet Thursday and Friday, Oct. 14-15, and we are getting our first look at the data the panel will be using to make its recommendation on booster shots for Moderna and Johnson & Johnson.
Merck asks FDA for emergency use authorization for COVID-19 pill
Read full article: Merck asks FDA for emergency use authorization for COVID-19 pillDrugmaker Merck asked U.S. regulators Monday to authorize its pill for treating COVID-19 in what would add an entirely new and easy-to-use weapon to the worldโs arsenal against the pandemic.
What to look for when choosing sunscreen
Read full article: What to look for when choosing sunscreenExperts suggest wearing sunscreen all day long when spending time outdoors, especially in the summer -- but with so many brands and types of sunscreen to choose from, picking the right one can be overwhelming.
FDA advisory panelist in Michigan explains voting in favor of Moderna COVID-19 vaccine
Read full article: FDA advisory panelist in Michigan explains voting in favor of Moderna COVID-19 vaccineANN ARBOR, Mich. โ The U.S. Food and Drug Administration granted an emergency use authorization for the Moderna COVID-19 vaccine Friday evening, the second vaccine to be authorized in the country. Prior to the authorization, the FDA advisory panel voted 20-0 with one abstention on Thursday to recommend the vaccine. UPDATE: US clears Moderna vaccine for COVID-19, 2nd shot in arsenalDr. A Oveta Fuller, a virologist and viral pathogen researcher at the University of Michigan, voted โNoโ to recommend the Pfizer vaccine. However, she said she voted โYesโ this time for Moderna. It seemed like their study was set up to meet that at the minimum but it wasnโt set up to do a whole lot else,โ Fuller said.
Hereโs a look at FDAโs COVID-19 vaccine review process
Read full article: Hereโs a look at FDAโs COVID-19 vaccine review processScientists with the U.S. Food and Drug Administration (FDA) are working to review two COVID-19 vaccines submitted by drug companies Pfizer and Moderna. Pfizer submitted its application on Nov. 20 for an emergency use authorization to the FDA Center for Biologics Evaluation and Research (CBER). โThe safety profile of a vaccine thatโs going to be deployed in millions of people has to be incredibly clean,โ said Dr. Peter Marks, who directs CBER. โWe, as an agency, are one of the last agencies in the world that we still actually get the primary data. We donโt get summary data.โCBER receives raw data on all participants in a vaccine trial, in addition to volumes of information on every aspect of the vaccine.
FDA authorizes rapid at-home COVID-19 test
Read full article: FDA authorizes rapid at-home COVID-19 testWhen it comes to COVID testing, weโve been hearing about growing lines and delayed results. But the Food and Drug Administration (FDA) issued a new emergency use authorization for an at-home test. The new test by California-based Lucira is a nasal swab test that can provide a result within 30 minutes and is for use by anyone ages 14 and older if their healthcare provider thinks they may have COVID-19. The nasal swab test involves swirling a patientโs self-collected sample swab in a vial, which is then placed in the test unit. The FDA did not talk about the price of the test but the companyโs website indicated that the test is intended to cost less than $50.